David D’Ambrosio, M.D. is a board-certified radiation oncologist and the Medical Director at New Jersey CyberKnife.
As part of an accelerated seven-year B.S./M.D. program, Dr. D’Ambrosio he earned his bachelor’s degree summa cum laude in biomedicine at the Sophie Davis School of Biomedical Education/City University of New York Medical School and his medical doctorate at State University of New York’s Stony Brook School of Medicine, where he graduated in the top 5% of his class. He was elected to Alpha Omega Alpha, the national medical honor society for all U.S. medical schools.
Formerly of Fox Chase Cancer Center in Philadelphia, Pennsylvania, Dr. D’Ambrosio began his residency at Fox Chase after completing his medical internship at Mount Sinai School of Medicine’s Cabrini Medical Center in New York City.
Dr. D’Ambrosio’s expertise includes intensity-modulated and stereotactic radiation therapies, including Cyberknife radiosurgery, head and neck cancer, prostate cancer, and lung cancer. He is skilled in brachytherapy (radioactive implants) for prostate, gynecologic and thoracic cancers, including the use of high-dose-rate temporary implants.
He has made several national and international presentations at annual meetings of the American Society for Therapeutic Radiology and Oncology and the American Radium Society, has published several peer-reviewed research papers on prostate cancer and lung cancer, and is one of the largest contributors to the international Radiosurgery Society (RSS) database, the RSSearch® Patient Registry.
Dr. D’Ambrosio is a member of the American Society of Clinical Oncology (ASCO), the American College of Radiology (ACR), and the American Society for Therapeutic Radiology and Oncology (ASTRO), where he serves on numerous committees.